Search
for
Sort by
Research 961–990 of 1000+
- Real-World, Open-Label Study of the Efficacy and Safety of a Novel Serum in Androgenetic Alopecia
- EVALUATE THE SAFETY AND EFFICACY OF LAPAROSCOPIC RESECTION VS OPEN SURGERY FOR THE CURATIVE CARE OF PATIENTS HAVING TUMORS OF THE RIGHT OR LEFT COLON
- Osteopontin regulatory functions in the hair follicle open a therapeutic approach for hypertrichosis
- Changes in Progesterone Metabolites in the Hippocampus Can Modulate Open Field and Forced Swim Test Behavior of Proestrous Rats
- Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Extensive alopecia areata treated with betamethasone oral mini-pulse therapy: an open uncontrolled study.
- Feline acne and results of treatment with mupirocin in an open clinical trial: 25 cases (1994–96)
- Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients
- Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
- Use of an Alternating Inflatable Head Pad inPatients Undergoing Open Heart Surgery
- Pharmacokinetic Interaction of Finasteride With Tamsulosin Hydrochloride: An Open-label, Randomized, 3-period Crossover Study in Healthy Chinese Male Volunteers
- A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata
- Turpentine Ointment for the Treatment of Folliculitis: An Open, Prospective, Randomized, Placebo- and Comparator-Controlled Multicenter Trial
- A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty
- Treatment of chronic alopecia areata with tildrakizumab: an open‐label pilot study
- LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor
- A 6-Month Prospective, Open-Label, Randomized Study Showing Increased Hair Growth Rate in Women Using Multi-Targeting Hair Growth Nutraceuticals
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- A comparative, open-label, randomised study; evaluating efficacy of a hand-held device using a combination of vibration and cold, versus only vibration; in reducing the pain sensation of multiple local anaesthesia injections during hair transplant
- A Single-Arm, Open-Label, Phase Ib Clinical Study Evaluating the Efficacy and Safety of Durvalumab in Combination with Albumin-Bound Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable Stage III Non-Small Cell Lung Cancer
- Supplementary Material for: Turpentine ointment for the treatment of folliculitis – an open, prospective, randomized, placebo- and comparator-controlled multicenter trial
- Supplementary Material for: Turpentine ointment for the treatment of folliculitis – an open, prospective, randomized, placebo- and comparator-controlled multicenter trial
- Efficacy and safety of a botanical shampoo containing <i>Morus alba</i> root extract in Republic of Korea: a single-center, open-label, pilot study in mild to moderate non-scarring alopecia of the scalp
- Comparative Efficacy of Topical Minoxidil Alone Against Combination of Topical Minoxidil and Platelet Rich Plasma in Women with Female Pattern Hair Loss-A Pilot, Open Randomised Trial.
- A randomised, open label comparative study of hydroxychloroquine with betamethasone oral mini pulse in the management of patients with alopecia areata
- OP-043 Quality of Life After Endovascular Repair Versus Open Surgery for Abdominal Aortic Aneurysms
- Nonablative radiofrequency for the treatment of androgenetic alopecia: An open‐label study
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
- Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study
- Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.